Internet-delivered therapy for PTSD and chronic pain

Internet-based Acceptance and Commitment Therapy for PTSD and Chronic Pain

Not applicable Interventional Skane University Hospital · NCT05147948

This study is testing whether online therapy can help people with PTSD and chronic pain feel better compared to those who wait to start the treatment.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment40 (estimated)
Ages18 Years to 65 Years
SexAll
SponsorSkane University Hospital Academic / other
Locations1 site (Lund)
Trial IDNCT05147948 on ClinicalTrials.gov

What this trial studies

This study investigates the effects of Internet-delivered Acceptance and Commitment Therapy (iACT) on individuals suffering from PTSD and chronic pain. It employs a randomized controlled trial design with a waitlist control group, where participants are divided into two groups: one receiving iACT and the other placed on a waitlist for 12 weeks before receiving the same treatment. The study aims to assess the efficacy of this therapeutic approach through baseline and post-treatment evaluations, including self-report measures and clinician-administered assessments. Participants will be recruited from the Pain Rehabilitation Unit at Skåne University Hospital, ensuring a focused approach to chronic pain management.

Who should consider this trial

Good fit: Ideal candidates are individuals with a confirmed diagnosis of PTSD and chronic pain that significantly interferes with daily life.

Not a fit: Patients with severe psychiatric disorders or those who have experienced repeated traumatic events may not benefit from this study.

Why it matters

Potential benefit: If successful, this therapy could significantly improve the quality of life for patients suffering from both PTSD and chronic pain.

How similar studies have performed: Other studies have shown promise with similar Internet-delivered therapeutic approaches for mental health conditions, suggesting potential for success in this area.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* a CAPS of ≥25
* subjected to single traumatic events
* were able to understand Swedish
* had symptoms of chronic pain that interfered significantly with everyday life
* were fully examined medically and had received medical treatment if indicated
* were able to be an active part of the rehabilitation process, regain functioning in different life areas and participate in treatment interventions for approximately 5 hours every week
* stable dose of medication
* able to read and write in Swedish
* had access to a smart phone or computer with internet access

Exclusion Criteria:

* repeated and extensive traumatic events
* had other acute or severe psychiatric disorders or symptoms that warranted designation as the primary disorder (ongoing substance dependence, untreated bipolar disorder, OCD, psychotic symptoms, severe depression)
* were actively abusing analgesic medications (including narcotics), alcohol or other drugs
* had great difficulty to harbour and handle strong emotions that could lead to emotional outbursts or self-harming behavior
* had health risks due to medical reasons
* had social or economic difficulties or lack of social support that hindered behavior change
* current severe suicidal ideation that warranted immediate intervention (indicated by the MINI and a score of 3 to item 9 of the Patient Health Questionnaire 9-item version (PHQ9))

Where this trial is running

Lund

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions PtsdChronic PainPTSDChronic painACT
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.